title: Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.
abstract: Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.
authors.affiliation: Department of Medical Imaging, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Matthew F
authors.initials: MF
authors.lastname: Covington
authors.affiliation: Department of Neurology, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Scott
authors.initials: S
authors.lastname: Sherman
authors.affiliation: Department of Medical Imaging, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Denise
authors.initials: D
authors.lastname: Lewis
authors.affiliation: Department of Neurology, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Hong
authors.initials: H
authors.lastname: Lei
authors.affiliation: Department of Medical Imaging, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Krupinski
authors.affiliation: Department of Medical Imaging, Medicine and Biomedical Engineering, University of Arizona College of Medicine, Tucson, Arizona, United States of America.
authors.forename: Phillip H
authors.initials: PH
authors.lastname: Kuo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D050483:Dopamine Plasma Membrane Transport Proteins / Q000502:physiology*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000000981:diagnostic imaging; D009662:Nortropanes / Q000627:therapeutic use*; D020734:Parkinsonian Disorders / Q000000981:diagnostic imaging*; D017060:Patient Satisfaction; D011795:Surveys and Questionnaires; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D007457:Iodine Radioisotopes; D009662:Nortropanes; C519528:ioflupane